P value will definitely improve with a larger sample size, given the type of study and the measurements there are not going to be massive outliers (unless a patient took PPS and reported a massive increase in pain - unlikely)
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $103.1M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 28.5¢ | $11.35K | 39.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2361 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 78695 | 3 |
View Market Depth
| Last trade - 11.57am 09/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |